The systemic safety of fexofenadine HCl
- 1 July 1999
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 29 (S3) , 163-170
- https://doi.org/10.1046/j.1365-2222.1999.0290s3163.x
Abstract
Fexofenadine is a highly specific, H1‐receptor antagonist with a safety profile similar to placebo. In placebo‐controlled trials of seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (...Keywords
This publication has 9 references indexed in Scilit:
- Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performanceJournal of Allergy and Clinical Immunology, 1998
- Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging studyJournal of Dermatological Treatment, 1998
- FexofenadineDrugs, 1998
- Onset of Action, Efficacy, and Safety of a Single Dose of Fexofenadine Hydrochloride for Ragweed Allergy Using an Environmental Exposure UnitAnnals of Allergy, Asthma & Immunology, 1997
- Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- The clinical pharmacology of fexofenadine in childrenJournal of Allergy and Clinical Immunology, 1996
- 1009 Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1996
- A Comparison of Central and Peripheral Effects of Cetirizine and LoratadineJournal of International Medical Research, 1991
- The Urticarias Current Concepts in Pathogenesis and TreatmentDrugs, 1985